Project Grant 2051102

Award Date 8/15/21
Completion Date 5/31/22
Dollars Obligated $256K
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Eatontown, NJ, USA
Similar Awards
Vena Vitals Inc. received a $256,000 Project Grant award from the National Science Foundation on February 15, 2021 to support development of a beat-to-beat blood pressure monitor using micro-nanoscale wrinkled functional materials. The award is being used to fund research and development activities through December 31, 2022 under the NSF's Engineering program (CFDA 47.041). This program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering...
This National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I project under CFDA 47.084 - NSF Technology, Innovation, and Partnerships provides $275,000 to Medfree Inc., a minority-owned small business, to develop a novel, transcatheter device and procedure for the minimally invasive surgical revision and repair of the tricuspid valve. The project aims to address the significant unmet need for percutaneous treatment options for the over 1.6 million U.S. patients...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant of $275,000 awarded to Xtract Medical Inc. aims to develop and demonstrate the feasibility of a novel catheter-based system for improved removal of blood clots during mechanical thrombectomy procedures to treat venous thromboembolism (VTE). The proposed system is designed to effectively remove large blood clots while minimizing damage to blood vessels and reducing complications such as...
The National Science Foundation (NSF) has awarded a $455,718 Faculty Early Career Development (CAREER) Project Grant to Marquette University to develop a living, tissue-engineered heart valve substitute capable of growing with child recipients of congenital heart valve defects. The 5-year project, funded under the NSF Engineering program (CFDA 47.041), aims to create a durable, hydrodynamically functional heart valve using an origami-inspired design and patient-derived cells that can self-repair...
The National Science Foundation awarded a $255,911 Project Grant to Frontier Bio Corporation of Oakland, California under the Engineering federal grant program (CFDA 47.041). The grant will support the development of novel advanced manufacturing techniques for artificial blood vessels from August 15, 2021 through May 31, 2022. The Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award will further...
Visionaire Products, Inc. received a $256,000 Project Grant award from the National Science Foundation on February 15, 2021 to complete work by July 31, 2021. The grant was awarded under the NSF's Engineering program (CFDA 47.041) to support development of a novel, microfluidic device to improve collection and analysis of biopsy samples from ocular paracentesis procedures. Specifically, the funding enables Visionaire Products to advance a microfluidic technology designed to more efficiently...
The National Science Foundation Division of Civil, Mechanical, and Manufacturing Innovation awarded Vanderbilt University Medical Center a $300,000 Project Grant under the Engineering (47.041) federal grant program. The three-year award, issued on June 1, 2021 and concluding on May 31, 2024, will support collaborative research to understand the effects of flow on smooth muscle cells in an arteriole-sized microchannel. Specifically, VUMC will analyze flow conditions and interactions at the...
Utah Valley University received a two-year, $285,042 Project Grant award from the National Science Foundation Division of Civil, Mechanical, and Manufacturing Innovation under the Engineering (47.041) federal grant program. The award will support investigation into the effect of venous valve morphology on fluid flow conditions and disease. Specifically, the university will conduct research examining how the shape and structure of valves in veins impact fluid circulation and potential links to...
The National Science Foundation awarded Vena Vitals Inc. a $1 million cooperative agreement under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a wireless, continuous, non-invasive blood pressure monitoring device. The device aims to address the unmet need for real-time blood pressure monitoring of patients undergoing surgery or in critical care by capturing rapid fluctuations with high temporal resolution. Current technologies are limited in accuracy, cost...
Corveus Medical, Inc. was awarded a $255,841 Project Grant from the National Science Foundation under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop an extravascular bipolar catheter for targeted nerve ablation with minimal collateral damage to surrounding tissues. The grant aims to support the design and prototyping of a minimally invasive, catheter-delivered venous procedure for performing extravascular greater splanchnic nerve ablation. The proposed catheter...

Venarum Medical LLC received a $255,619 Project Grant award from the National Science Foundation on August 15, 2021 to support research and development activities concluding on May 31, 2022. The funding was provided through the NSF's Engineering program (CFDA #47.041), which aims to improve quality of life and economic strength through engineering innovation and excellence.

Specifically, the grant supports Venarum Medical's "SBIR PHASE I: INTEGRATED MANUFACTURING OF ARTIFICIAL VALVES FOR MEDICAL USE" project. The project focuses on R&D to advance the company's integrated manufacturing techniques for artificial heart valves with the goal of improving medical technology. The funding will allow Venarum Medical, located in Eatontown, New Jersey, to continue development of products and services in this area over the approximately 9-month grant period.

Generated 1/6/24, 5:34 PM